1.
Shkorik EV. New Immunological Markers of Thromboembolic and Hemorrhagic Complications after Coronary Artery Bypass Grafting. AJP [Internet]. 2017 Dec. 15 [cited 2026 Feb. 12];11(04). Available from: https://www.asiapharmaceutics.info/index.php/ajp/article/view/1734